123 related articles for article (PubMed ID: 31644823)
1. Chaperones in sporadic inclusion body myositis-Validation of proteomic data.
Güttsches AK; Jacobsen F; Schreiner A; Mertens-Rill J; Tegenthoff M; Marcus K; Vorgerd M; Kley RA
Muscle Nerve; 2020 Jan; 61(1):116-121. PubMed ID: 31644823
[TBL] [Abstract][Full Text] [Related]
2. Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis.
Güttsches AK; Brady S; Krause K; Maerkens A; Uszkoreit J; Eisenacher M; Schreiner A; Galozzi S; Mertens-Rill J; Tegenthoff M; Holton JL; Harms MB; Lloyd TE; Vorgerd M; Weihl CC; Marcus K; Kley RA
Ann Neurol; 2017 Feb; 81(2):227-239. PubMed ID: 28009083
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of alphaB-crystallin is associated with amyloid precursor protein and accumulation of beta-amyloid.
Muth IE; Barthel K; Bähr M; Dalakas MC; Schmidt J
J Neurol Neurosurg Psychiatry; 2009 Dec; 80(12):1344-9. PubMed ID: 19470495
[TBL] [Abstract][Full Text] [Related]
4. Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients.
Kierdaszuk B; Berdynski M; Palczewski P; Golebiowski M; Zekanowski C; Kaminska AM
Folia Neuropathol; 2015; 53(4):355-66. PubMed ID: 26785370
[TBL] [Abstract][Full Text] [Related]
5. Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis.
Lünemann JD; Schmidt J; Schmid D; Barthel K; Wrede A; Dalakas MC; Münz C
Ann Neurol; 2007 May; 61(5):476-83. PubMed ID: 17469125
[TBL] [Abstract][Full Text] [Related]
6. Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis.
Gang Q; Bettencourt C; Machado PM; Brady S; Holton JL; Pittman AM; Hughes D; Healy E; Parton M; Hilton-Jones D; Shieh PB; Needham M; Liang C; Zanoteli E; de Camargo LV; De Paepe B; De Bleecker J; Shaibani A; Ripolone M; Violano R; Moggio M; Barohn RJ; Dimachkie MM; Mora M; Mantegazza R; Zanotti S; Singleton AB; Hanna MG; Houlden H;
Neurobiol Aging; 2016 Nov; 47():218.e1-218.e9. PubMed ID: 27594680
[TBL] [Abstract][Full Text] [Related]
7. Chaperone-mediated autophagy components are upregulated in sporadic inclusion-body myositis muscle fibres.
Cacciottolo M; Nogalska A; D'Agostino C; Engel WK; Askanas V
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):750-61. PubMed ID: 23452232
[TBL] [Abstract][Full Text] [Related]
8. [Inclusion body myositis].
Suzuki N; Aoki M
Brain Nerve; 2011 Nov; 63(11):1205-15. PubMed ID: 22068473
[TBL] [Abstract][Full Text] [Related]
9. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
Schmidt J; Rakocevic G; Raju R; Dalakas MC
Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
[TBL] [Abstract][Full Text] [Related]
10. Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis.
Pinkus JL; Amato AA; Taylor JP; Greenberg SA
Neuromuscul Disord; 2014 Jul; 24(7):611-6. PubMed ID: 24857366
[TBL] [Abstract][Full Text] [Related]
11. [Sporadic inclusion body myositis and amyloid].
Aoki M; Suzuki N
Brain Nerve; 2014 Jul; 66(7):739-48. PubMed ID: 24998819
[TBL] [Abstract][Full Text] [Related]
12. CYLD dysregulation in pathogenesis of sporadic inclusion body myositis.
Yamashita S; Matsuo Y; Tawara N; Hara K; Yamamoto M; Nishikami T; Kawakami K; Zhang X; Zhang Z; Doki T; Ando Y
Sci Rep; 2019 Aug; 9(1):11606. PubMed ID: 31406156
[TBL] [Abstract][Full Text] [Related]
13. Gain and loss of extracellular molecules in sporadic inclusion body myositis and polymyositis--a proteomics-based study.
Doppler K; Lindner A; Schütz W; Schütz M; Bornemann A
Brain Pathol; 2012 Jan; 22(1):32-40. PubMed ID: 21672074
[TBL] [Abstract][Full Text] [Related]
14. Sequestosome-1 (p62) expression reveals chaperone-assisted selective autophagy in immune-mediated necrotizing myopathies.
Fischer N; Preuße C; Radke J; Pehl D; Allenbach Y; Schneider U; Feist E; von Casteleyn V; Hahn K; Ruck T; Meuth SG; Goebel HH; Graf R; Mammen A; Benveniste O; Stenzel W
Brain Pathol; 2020 Mar; 30(2):261-271. PubMed ID: 31376301
[TBL] [Abstract][Full Text] [Related]
15. [Sporadic inclusion body myositis in Japan].
Aoki M; Suzuki N
Nihon Rinsho; 2012 May; 70(5):895-906. PubMed ID: 22620019
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β signaling is upregulated in sporadic inclusion body myositis.
Noda S; Koike H; Maeshima S; Nakanishi H; Iijima M; Matsuo K; Kimura S; Katsuno M; Sobue G
Muscle Nerve; 2017 May; 55(5):741-747. PubMed ID: 27623743
[TBL] [Abstract][Full Text] [Related]
17. Clinical, Histological, and Immunohistochemical Findings in Inclusion Body Myositis.
de Camargo LV; de Carvalho MS; Shinjo SK; de Oliveira ASB; Zanoteli E
Biomed Res Int; 2018; 2018():5069042. PubMed ID: 29780824
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of autophagic proteins in the skeletal muscle of sporadic inclusion body myositis.
Girolamo F; Lia A; Amati A; Strippoli M; Coppola C; Virgintino D; Roncali L; Toscano A; Serlenga L; Trojano M
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):736-49. PubMed ID: 23452291
[TBL] [Abstract][Full Text] [Related]
19. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.
Rojana-udomsart A; Needham M; Luo YB; Fabian V; Walters S; Zilko PJ; Mastaglia FL
Clin Neurol Neurosurg; 2011 Sep; 113(7):559-63. PubMed ID: 21507567
[TBL] [Abstract][Full Text] [Related]
20. Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.
Gang Q; Bettencourt C; Machado P; Hanna MG; Houlden H
Orphanet J Rare Dis; 2014 Jun; 9():88. PubMed ID: 24948216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
